The Claim
Human lung macrophages constitutively express both membrane-bound (flRAGE) and soluble (sRAGE) forms of the receptor for advanced glycation end products, and exposure to AGEs increases sRAGE mRNA expression without changing RAGE protein levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human lung macrophages, two forms of the RAGE receptor are always present: one attached to the cell membrane and one released into the surrounding fluid. When exposed to advanced glycation end products, the amount of mRNA for the soluble form increases, while the amount of membrane-bound protein remains unchanged.
See the scientific wording
Human lung macrophages constitutively express both membrane-bound (flRAGE) and soluble (sRAGE) forms of the receptor for advanced glycation end products, and exposure to AGEs slightly upregulates sRAGE mRNA without altering RAGE protein levels, suggesting a potential compensatory mechanism to modulate inflammatory signaling.
When harmful AGE molecules bind to the RAGE receptor on lung macrophages, the cells respond by making more sRAGE messenger RNA, which acts as a decoy to soak up excess AGEs and reduce inflammation, even though the number of RAGE receptors on the cell surface stays the same.
What the research says
1 studyWhen lung immune cells are exposed to harmful compounds called AGEs, they make more of a special 'sponge' molecule (sRAGE) that can soak up those compounds, possibly to calm down inflammation — even though the main receptor on their surface doesn’t change.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.